MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...

Russian internet company VK on Thursday said its net loss in 2024 had almost tripled in size to 94.9 billion roubles ($1.13 billion), up from 34.3 billion roubles the year before. VK said expenses for ...

Russian tech giant VK posted a staggering net loss of 94.94 billion rubles ($1.12 billion) in 2024 — nearly three times the ...

Delhi Lieutenant Governor VK Saxena had in July 2022 flagged the DDA's finances being in "red" and asserted to make it a profit earning agency, the LG office said in a post on X. "From perennially ...

Sattva Sukun Lifecare Ltd., incorporated in the year 1980, is a Small Cap company (having a market cap of Rs 19.78 Crore) operating in Trading sector. Sattva Sukun Lifecare Ltd. key Products/Revenue ...